> Protalex says the FDA has lifted a clinical hold on its lead product PRTX-100, allowing the drug developer to proceed with a Phase I trial. Release
> The FDA has approved Lupin's ANDA for Lisinopril tablets, the generic equivalent of Astra Zeneca's Zestril. Story
> Alnylam and Carlsbad, California-based Isis Pharmaceuticals have inked a deal to license research on a MicroRNA gene needed to replicate hepatitis C. Report
> An early-stage trial of Novogen's cardiovascular drug NV-04 resulted in improvements in blood pressure and arterial stiffness. Release
> San Diego-based Ligand Pharmaceuticals says the SEC has opened a probe of its restatement of the company's financial reports. Release
> Chutes & Ladders: Oragenics has named acting president and CEO Robert Zahradnik to the post permanently. Story
And Finally… British regulators say they'll investigate whether a plan to cap drug profits from sales to the National Health Service is working and will consider charges against any drug company that hasn't complied. Article